What the buyer wrote
UK Biobank requires a sequencing provider that can offer Whole Genome Sequencing (WGS) services that meet the requirements outlined in this specification. The key parameters for any bidder are as follows: • There is up to £30m funding available for a vanguard phase of whole genome sequencing; • The scope of the tender is for sequencing (and certain named ancillary) services only; • The sequencing for this vanguard phase should ideally be completed by the end of 2019 (see section 1.2.1 for preferred timetable). Additional information: UK Biobank is issuing this tender to invite Bids to conduct a vanguard phase of whole genome sequencing. The principal purpose of this vanguard phase i…
Bid for this and lost? There is a short window in which the decision can be questioned.
Awarded to
Details
- What the buyer calls it
- Whole Genome Sequencing
- How they are buying
- Advertised, open to anyoneAny supplier could bid without being invited first.
- Type
- services
- Work starts
- 29 Mar 2018
- Work ends
- 31 Mar 2021
- Kind of work
- Health and social care
Who the buyer named
Josef Braithwaite was the named contact on this notice.
